October 22, 2024 12:31 PM EDTUpdated 05:33 PM
Deals
Manufacturing

Sam­sung Bio inks largest deal yet worth $1.24B with un­named Asian phar­ma 

Anna Brown

News Reporter

Sam­sung Bi­o­log­ics has so far se­cured at least five ma­jor con­tracts this year, and its lat­est with an un­named Asia-based phar­ma­ceu­ti­cal com­pa­ny is its largest …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times